As public expectations for equity in healthcare rise, pharmaceutical companies are shifting toward more inclusive manufacturing and packaging models. Designing for everyone, regardless of individual characteristics, is no longer optional. PHARMAP 2026 This transformation will be addressed with a specialized session on patient-centered design and its role in modern medicine. The event will take place on April 20 and 21 in Amsterdam.
Trust and interaction are now paramount, with 90% of healthcare systems considering patient experience a top priority. This shift has transformed patient-centered medicine into a data-driven, operational reality. By integrating patient input from the preclinical phase, pharmaceutical companies are redefining the design and evaluation of modern medicine.
Bayer AG It is transforming clinical research through its ALYCE platform, using AI and data centers to power decentralized trials that prioritize patient convenience. However, these digital solutions are not the endpoint of the company's evolution. They represent only one facet of a broader strategy. At PHARMAP 2026, Robin Falter, Director of Value Chain at Bayer, It demonstrates how this vision applies to physical products, sharing its expertise in patient-centered packaging.
The session also includes the participation of Karel van der Waarde, from HSLU, A pioneering institution in personalized medicine research. An excellent example of this work is HSLU's Interdisciplinary Health Network (IDN), created in 2024 to unite its six faculties in developing sustainable healthcare solutions. The network already drives more than 50 collaborative research and publishing initiatives, providing direct context for van der Waarde's ideas on optimizing medical information for patients and caregivers.
Understanding the patient's perspective on packaging and information is more essential than ever in today's high-demand market. Joost Groen, Independent Patient Empowerment Consultant at Sidewise, Join the session to contribute strategic insights on how to optimize packaging to meet patient needs. A patient-centered approach is the future, and with the right information, the industry is poised for significant progress. PHARMAP 2026 facilitates a high-level dialogue on the technologies shaping this transition.
You can discover the business program at https://sh.bgs.group/3u8.
